Benitec Biopharma  logo
Benitec Biopharma BNTC
$ 10.36 -2.86%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Benitec Biopharma Income Statement 2011-2024 | BNTC

Annual Income Statement Benitec Biopharma

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

35.7 M 4.09 M 351 K 8.59 M 7.66 M 8.5 M 29.5 M 18.9 M 12.2 M 75.9 M 27.4 M - - -

Shares

4.06 M 1.39 M 481 K 4.3 M 1.02 M 858 K 702 K 585 K 474 K 385 K 96.3 K - - -

Historical Prices

8.79 2.95 0.73 2.32 3.15 7.77 27.1 44.2 40.3 22.6 190 - - -

Net Income

-21.8 M -19.6 M -18.2 M -13.9 M -8.27 M 2.87 M -8.55 M -4.37 M -18.5 M -8.83 M -10.8 M -6.42 M - -

Revenue

- 75 K 73 K 59 K 97 K 11.3 M 455 K 450 K 347 K 829 K 1.02 M 546 K - -

Cost of Revenue

- - - - - - - - - - - - - -

Gross Profit

- - - - 282 K 10.9 M 124 K 241 K 243 K 798 K 980 K 370 K - -

Operating Income

-22.5 M -19.1 M -17.9 M -13.6 M -8.28 M 2.58 M - - - - - - - -

Interest Expense

-204 K -30 K -79 K 37 K 34 K - - - - - - - - -

EBITDA

-22.4 M -18.9 M -17.7 M -13.4 M -7.91 M 2.69 M -8.41 M -4 M -13.4 M -7.93 M -9.9 M -6.64 M - -

Operating Expenses

22.5 M 19.2 M 17.9 M 13.7 M 8.56 M 8.35 M 8.68 M 4.4 M 16.2 M 8.8 M 11.3 M 7.11 M - -

General and Administrative Expenses

6.99 M 6.38 M 6.65 M 6.51 M 5.57 M 6.66 M 6.41 M 6.99 M 8.96 M 6.17 M 7.67 M 4.39 M - -

All numbers in USD currency

Quarterly Income Statement Benitec Biopharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

10.6 M 10.1 M 2.62 M 2.58 M 2.16 M 1.67 M 1.65 M 1.62 M 639 K 8.17 M 8.17 M 8.17 M 8.17 M 8.17 M 4.75 M 4.3 M 1.11 M 4.3 M 1.11 M 1.04 M 859 K 857 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-5.06 M - -4.28 M -6.8 M -5.95 M - -4.4 M -5.41 M -5.09 M -10.5 M -3.28 M -4.82 M -5.04 M -9.87 M -5.04 M -3.25 M -3.25 M -3.25 M -2.72 M -2.09 M -1.15 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - 54 K 14 K - 14 K 48 K 25 K - 25 K 1 K 1 K 55 K 1 K 55 K 77 K 33 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-5.79 M - -4.14 M -6.93 M -5.87 M - -4.34 M -5.61 M -4.58 M -10.2 M -3.46 M -4.84 M -4.82 M -9.66 M -3.79 M -3.26 M -2.69 M -3.26 M -2.69 M -2.11 M -1.17 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

35 K - -16 K -16 K -18 K - - 50 K - 50 K -29 K - 37 K - - 10 K 27 K 10 K 27 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-5.77 M - -4.12 M -6.91 M -5.86 M - -4.31 M -5.57 M -4.54 M -10.1 M -3.41 M -4.78 M -4.77 M -9.55 M -3.73 M -3.19 M -2.64 M -3.15 M -2.64 M -2.06 M -1.12 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

5.79 M - 4.14 M 6.93 M 5.87 M - 4.4 M 5.62 M 4.58 M 10.2 M 3.51 M 4.86 M 4.82 M 9.68 M 3.79 M 3.26 M 2.74 M 3.26 M 2.74 M 2.19 M 1.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

2.21 M - 1.58 M 1.82 M 1.55 M - 1.23 M 1.86 M 1.92 M 3.78 M 1.34 M 1.71 M 2.04 M 3.76 M 1.03 M 2.11 M 1.84 M 2.11 M 1.84 M 1.9 M 750 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency